IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BELLONE, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.625
AS - Asia 678
EU - Europa 412
SA - Sud America 137
AF - Africa 10
OC - Oceania 2
AN - Antartide 1
Totale 2.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.591
SG - Singapore 230
CN - Cina 227
UA - Ucraina 117
BR - Brasile 111
HK - Hong Kong 68
IT - Italia 59
DE - Germania 55
FI - Finlandia 52
VN - Vietnam 52
FR - Francia 29
IN - India 24
TR - Turchia 24
CA - Canada 23
GB - Regno Unito 20
IE - Irlanda 17
RU - Federazione Russa 16
BD - Bangladesh 14
AR - Argentina 13
MX - Messico 8
ID - Indonesia 7
NL - Olanda 7
PL - Polonia 7
SE - Svezia 6
EC - Ecuador 5
JP - Giappone 5
ES - Italia 4
IQ - Iraq 4
LT - Lituania 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AT - Austria 3
BE - Belgio 3
CZ - Repubblica Ceca 3
KG - Kirghizistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
PK - Pakistan 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 2.865
Salva come PNG Salva come JPEG
Città #
Fairfield 180
Woodbridge 158
Ashburn 148
Singapore 132
Houston 113
Jacksonville 76
Wilmington 72
Ann Arbor 68
Hong Kong 67
Seattle 67
Cambridge 62
New York 56
Beijing 43
Dearborn 43
San Jose 37
Nanjing 34
Helsinki 33
Chandler 32
Los Angeles 31
Princeton 30
Indianapolis 27
The Dalles 25
Ho Chi Minh City 20
Istanbul 18
Dublin 17
Lauterbourg 16
Orem 16
Shanghai 14
Hanoi 13
San Francisco 13
Chicago 12
São Paulo 12
Toronto 12
Moscow 11
Shenyang 11
Des Moines 10
Munich 10
Denver 9
Chennai 8
Milan 8
Montreal 8
Nanchang 8
San Diego 8
Kunming 7
Redondo Beach 7
Belo Horizonte 6
Dallas 6
Mooresville 6
Rome 6
Santa Clara 6
Warsaw 6
Amsterdam 5
Atlanta 5
Brooklyn 5
Buffalo 5
Hebei 5
Jiaxing 5
Jinan 5
Ningbo 5
Paris 5
Tianjin 5
Tokyo 5
Boston 4
Brescia 4
Da Nang 4
Mumbai 4
Nuremberg 4
Stockholm 4
Turku 4
Arezzo 3
Bishkek 3
Brasília 3
Brussels 3
Changsha 3
Charlotte 3
Guangzhou 3
Guarulhos 3
Hangzhou 3
Hefei 3
Kilburn 3
London 3
Monmouth Junction 3
Pelotas 3
Querétaro 3
Amman 2
Auburn Hills 2
Baghdad 2
Baku 2
Bismarck 2
Biên Hòa 2
Boardman 2
Catanduva 2
Chongqing 2
City of London 2
Council Bluffs 2
Dammam 2
Diadema 2
Frankfurt am Main 2
Greenville 2
Hải Dương 2
Totale 1.998
Salva come PNG Salva come JPEG
Nome #
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 220
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 207
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 197
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 190
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. 184
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 182
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 164
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 163
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. 161
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 158
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 155
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 147
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) 146
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 144
Serum amyloid A: a novel biomarker for endometrial cancer. 121
Integrated mutational landscape analysis of uterine leiomyosarcomas 112
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 91
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 83
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 83
Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody. 2
Totale 2.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 24 26 8
2021/2022155 24 34 0 2 1 11 11 6 4 22 14 26
2022/2023138 22 3 3 6 13 27 5 16 18 0 13 12
2023/2024173 13 11 20 4 8 38 13 5 33 6 1 21
2024/2025307 1 4 2 37 22 37 20 7 38 23 76 40
2025/2026907 94 93 74 199 120 59 155 21 44 48 0 0
Totale 2.910